LiNA MEDICAL

Executive Summary

LiNA MEDICAL, based in Glostrup, Denmark, is a private medical device company dedicated to advancing gynecological surgery and improving patient outcomes. Founded in 1997, the company focuses on developing innovative surgical solutions and fostering strong connections with healthcare professionals through participation in society conferences and educational initiatives. By collaborating closely with surgeons and healthcare providers, LiNA MEDICAL aims to enhance surgical techniques and patient care in gynecology worldwide. The company operates within the medical devices and surgery categories, emphasizing continuous innovation and clinical excellence. Despite being a well-established player in the gynecological device space, LiNA MEDICAL remains privately held with limited public financial disclosures. Its strategic emphasis on surgeon education and conference engagement suggests a commitment to building brand loyalty and driving adoption of its products. The company's long tenure and focused mission indicate stability, but the lack of disclosed funding rounds, regulatory milestones, or commercial product details makes it challenging to assess near-term growth prospects. Overall, LiNA MEDICAL appears to be a niche player with a steady market presence, though its private nature limits visibility into specific growth drivers.

Upcoming Catalysts (preview)

• Q4 2026Launch of next-generation surgical device for minimally invasive gynecology60% success
• Q2 2027FDA 510(k) clearance for a novel uterine manipulator or laparoscopic instrument50% success
• Q3 2026Strategic partnership with a major healthcare distributor to expand global reach40% success